Form 4: TransDigm COO Joel Reiss Executes Stock Option Exercise

TransDigm Group Co-Chief Operating Officer Joel Reiss exercised 3,900 stock options and subsequently sold the shares on April 15, 2026.

Summary

• Joel Reiss, Co-Chief Operating Officer of TransDigm Group, exercised 3,900 stock options at a strike price of $284.97.
• Following the exercise, the reporting person sold the acquired shares in multiple transactions on April 15, 2026.
• The sale prices ranged from approximately $1,273.85 to $1,294.80 per share.
• The transaction was conducted pursuant to a Rule 10b5-1(c) trading plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative transaction by an executive, which is neutral in nature and typical for equity compensation programs.

Positives

• The transaction demonstrates the exercise of long-held equity incentives, reflecting the executive's participation in the company's long-term value creation.

Negatives

• The immediate sale of the acquired shares reduces the executive's direct equity stake in the company.

Risks

• None identified in this specific Form 4 filing.

Future Outlook

No forward-looking guidance provided in this document.

Industry Context

StockSavvy.ai notes that insider selling via 10b5-1 plans is a standard practice for executives to manage personal liquidity and diversify portfolios, and does not necessarily reflect a change in management's outlook on the company's performance.

Comparison to Industry Standards

• The use of Rule 10b5-1 trading plans is a standard corporate governance practice among S&P 500 executives to avoid potential conflicts of interest regarding material non-public information.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was pre-planned under a 10b5-1 rule.

Next Steps

• None mentioned.

Key Dates

Keywords

TransDigm, TDG, Insider Trading, Form 4, Stock Options, Aerospace